Sudarshan Pharma Completes Divestment of 51% Stake in Ishwari Healthcare
Sudarshan Pharma Industries Ltd 路 Others (Uncategorized) 路 28 Sept 2026, 11:08 pm
Sudarshan Pharma Completes Divestment of 51% Stake in Ishwari Healthcare Sudarshan Pharma Industries Ltd completed the sale of its entire 51.00% equity stake in subsidiary Ishwari Healthcare Private Limited on 28th Sep'26. The transaction comprised 2,09,100 equity shares (face value Rs. 10 each) sold to Mr. Amit Jatin Mehta for an aggregate consideration of Rs. 1.40 Crores. Following the divestment, Sudarshan Pharma's shareholding in Ishwari Healthcare has been reduced to nil, and Ishwari Healthcare has ceased to be a subsidiary of the company.
Original exchange filing (PDF)
More announcements from Sudarshan Pharma Industries Ltd
- Pursuant to Regulation 30 and other applicable Regulations, if any, of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations''), we inform .... 路 09 Nov 2026
- In terms of Regulation 30 read with Para A of Part A of Schedule III to the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, we hereby submit the updated Investor .... 路 07 Nov 2026
- In continuation of the Company''s letter dated 30/Oct/2026 (ref. no. SPIL/CS/2026-2027/72), the Board of Directors at its Meeting held on 29/Oct/2026 have approved the proposal to raising .... 路 31 Oct 2026
- This is to inform you that the Board of Directors of the Company at its Board Meeting held on 29/Oct/2026 has approved the proposal to raising funds through issue and allotment of up to .... 路 30 Oct 2026
- We are submitting herewith the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/Sep/2026 路 30 Oct 2026
- We are submitting the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/Sep/2026 路 30 Oct 2026
- Sudarshan Pharma Industries Limited has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Fund raising. 路 29 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 and Fund Raising 路 29 Oct 2026
